Abstract
Designing means to deliver peptide and protein drugs successfully to the systemic circulation by the oral route has been a challenge to scientists in drug delivery for many years [1]. The barriers to peptide and protein absorption from the gastrointestinal tract are well known. There are the enzymatic and penetration barriers [2–4]. Of the two, the enzymatic barrier historically has received more attention and appears to be the rate-limiting step in the intestinal penetration of small peptides such as leucine enkephalin and its analogs [5]. Numerous investigations have focused on the use of protease inhibitors, notably aprotinin [6–8], soy bean trypsin inhibitor [8–10], and amastatin [5] and on the use of formulations, notably microparticulates [11] to protect the encapsulated peptide and protein drugs from luminal proteases.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Lee VHL, Dodda-Kashi S, Grass GM, Rubas W (1991) Oral route of peptide and protein drug delivery. In. Lee VHL (ed) Peptide and protein drug delivery. Dekker, New York, pp 691–738
Lee VHL (1990) Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J Contr Rel 13:213–223
Lee VHL, Yamamoto A (1990) Penetration and enzymatic barriers to peptide and protein abosrption. Adv Drug Deliv Rev 4:171–207
Schilling RJ, Mitra AK (1991) Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm Res 8:721–727
Friedman DI, Amidon GL (1991) Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues. Pharm Res 8:93–96
Parsons JA, Rafferty B, Stevenson RW, Zanelli JM (1977) Use of protease inhibitors to protect subcutaneously injected peptide hormones against local degradation. Br J Pharmacol 59: 489P-490P
Parsons JA, Rafferty B, Stevenson RW, Zanelli JM (1979) Evidence that protease inhibitors reduce the degradation of parathyroid hormone and calcitonin injected subcutaneously. Br J Phannacol 66:25–32
Morimoto K, Yamaguchi H, Iwakura Y, Miyazaki M, Nakatani E, Iwamoto T, Ohashi Y, Nakai Y (1991) Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue. Phann Res 8:1175–1179
Kidron M, Bar-On J, Berry EM, Ziv E (1982) The absorption of insulin from various regions of the rat intestine. Life Sci 31:2837–2841
Ziv E, Lior O, Kidron M (1987) Absorption of protein via the intestinal wall: a quantitative model. Biochem Phannacol 36:1035–1039
Damge C, Michel C, Aprahamian M, Couvreur P (1988) New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37:246–251
Moore JA, Pletcher SA Ross MJ (1986) Absorption enhancement of growth hormone from the gastrointestinal tract of rats. Int J Phann 34:35–43
Nishihata T, Rytting JH, Kamada A, Higuchi T (1981) Enhanced intestinal absorption of insulin in rats in the presence of sodium 5-methoxysalicylate. Diabetes 30:1065–1067
Peters GE, Hutchinson LEF, Hyde R, McMartin C, Metcalfe SB (1987) Effect of sodium 5-methoxysalicylate on macromolecule absorption and mucosal morphology in a vascularly perfused rat gut preparation in vivo. J Phann Sci 76:857–861
Takada K, Shibata N, Yoshimura H, Masuda Y, Yoshikawa H, Muranishi S, Oka T (1985) Promotion of the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles. J Pharmacobio-Dyn 8:320–323
Sekine M, Sasahara K, Kojima T, Hasegawa K, Okada R, Awazu S (1984) Improvement of bioavailability of poorly absorbed drugs. I. Effect of medium chain glyceride base on the rectal absorption of cefmetazole sodium in rats. J Phannacobio-Dyn 7:856–863
Sekine M, Terashima H, Sasahara K, Nishimura K, Okada R, Awazu S (1985) Improvement of bioavailability of poorly absorbed drugs. II. Effect of medium chain glyceride base on the intestinal absorption of cefmetazole sodium in rats and dogs. J Phannacobio-Dyn 8:286–295
Muranishi S, Muranushi N, Sezaki H (1979) Improvement of absolute bioavailability of normally poorly absorbed drugs: Inducement of the intestinal absorption of streptomycin and gentamicin by lipid-bile salt mixed micelles in rat and rabbit. Int J Phann 2:101–111
Bocci V, Naldini A, Corradesc F, Lencioni E (1985) Colorectal administration of human interferon-yo Int J Phann 24:109–114
LeCluyse EL, Appel LE, Sutton SC (1991) Relationship between drug absorption enhancing activity and membrane perturbing effects of acylcamitines. Phann Res 8:84–87
Fix JA, Engle K, Porter PA, Leppert PS, Selk SJ, Gardner CR, Alexander J (1986) Acylcamitines: Drug absorption-enhancing agents in the gastrointestinal tract. Am J Physiol 251: G332-G340
Ferry DM, Butt TJ, Broom MF, Hunter J, Chadwick VS (1989) Bacterial chemotactic oligopeptides and the intestinal mucosal barrier. Gastroenterology 97:61–67
Sutton SC, LeCluyse EL, Cammack L, Fix FA (1992) Enhanced bioavailability of cefoxitin using palmitoyl-L-camitine. I. Enhancer activity in different intestinal regions. Phann Res 9: 191–194
Smith PL, Wall DA, Gochoco CH, Wilson G (1992) Oral absorption of peptides and proteins. Adv Drug Deliv Rev (8:253–290)
Shen WC, Wan J, Ekrami H (1992) Enhancement of polypeptide and protein absorption by macromolecular carriers via endocytosis and transcytosis. Adv Drug Deliv Rev 8: 93–113
Sawchuck RJ, Awni WM (1986) Absorption of cyclosporine from rabbit small intestine in situ. J Phann Sci 75:1151–1156
Jennewein HM, Waldeck F, Konz W (1974) The absorption oftetragastrin from different sites in rats and dogs. Arzneimittelforschung 24:1225–1228
Lundin S, Vilhardt H (1986) Absorption of I-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in rabbits. Acta Endocrinol 112: 457–460
Kohler E, Duberow DM, Drew J, Ribes G, Loubatieres MMM, Mazer N, Gyr K, Berlinger C (1987) Absorption of an aqueous solution of a new synthetic somatostatin analogue administered to man by gavage. Eur J Clin Phannacol 33:167–171
Grass GM, Morehead WJ (1989) Evidence for site-specific absorption of a novel ACE inhibitor. Phann Res 6:759–765
Lundin S, Pantzar N, Broeders A, Ohlin M, Westrom BR (1991) Differences in transport rate of oxytocin and vasopressin analogues across proximal and distal isolated segments of the small 1.intestine of the rat. Phann Res 8:1274–1280
Kompella UB, Lee VHL (1992) Delivery systems for penetration enhancement of peptide and protein drugs: Design considerations. Adv Drug Deliv Rev 8:115–162
Rubinstein A, Nakar D, Sintov A (1992) Colonic drug delivery: enhanced release of indo- methacin from cross-linked chondroitin matrix in rat cecal content. Pharm Res 9: 276–278
Salyers AA, O’Brien M (1980) Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thetaiotaomicron. J Bacterid 143:772–780
Saffran M, Kumar GS, Savariar C, Burnham JC, Williams F, Neckers DC (1986) A new approach to the oral administration of insulin and other peptide drugs. Science 23:1081–1084
Heringova A, Koldovsky O, Jirosova V, Uher J, Noack R, Freidrich M, Schenk G (1966) Proteolytic and peptidase activities of the small intestine of human fetuses. Gastroenterology 51:1023–1027
Triadou N, Bataille J, Schmitz J (1983) Longitudinal study of the human intestinal brush border membrane proteins. Gastroenterology 85:1326–1332
Shoji Y, Lee VHL (1989) Regional differences in the proteolysis of a renin inhibitor in the G.I. tract of the albino rabbit. Pharm Res 6S:31
Shoji Y, Lee VHL (1989) Prolyl endoprotease (E.C.3.4.21.26) activity in the colon and its role in the degradation of thyrotropin releasing hormone in the albino rabbit. Pharm Res 6S: 31
Buur A, Yamamoto A, Lee VHL (1990) Penetration of 5-fluorouracil and prodrugs across the intestine of the albino rabbit: evidence for shift in absorption site from the upper to the lower region of the gastrointestinal tract by prodrugs. J Contr Rel 14:43–51
Narawane M, Podder SK, Bundgaard H, Lee VHL (1993) Segmental differences in drug permeability, esterase activity and ketone reductase activity in the albino rabbit intestine. J. Drug Targeting 1:29–39
Conradi RA, Hilgers AR, Ho NFH, Burton PS (1991) The influence of peptide structure on transport across CaCO-2 cells. Pharm Res 8:1453–1460
Cereijido M, Meza I, Martinez-Palomo A (1981) Occluding junctions in cultured epithelial monolayers. Am J Physiol 240:C96-C102
Madara JL, Dharmsathaphorn K (1985) Occluding junction structure-function relationships in a cultured epithelial monolayer. J Cell Biol 101:2124–2133
Yen WC, Lee VHL (1991) Influence of collagenase on the intestinal transport of a pentapeptide. Proceed Intern Symp Control Rel Bioact Mater 18:95
Dolye JW, Wolfe MM, McGuigan JE (1984) Hepatic clearance of gastrin and cholecystokinin peptides. Gastroenterology 87:60–68
Gores GJ, LaRusso NF, Miller LJ (1986) Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. Am J Physiol 250:G344-G349
Sakamoto T, Fujimura M, Newman J, Zhu XG, Greeley GH, Thompson JC (1985) Comparison of hepatic elimination of different forms of cholecystokinin in dogs. J Clin Invest 75:280–285
Hunter EB, Powers SP, Kost LJ, Pinon DI, Miller LJ, LaRusso NF (1990) Physiochemical determinants in hepatic extraction of small peptides. Hepatology 12:76–82
Dobrinska MR (1989) Enterohepatic circulation of drugs. J Clin Phar 29:577–580
Renston RH, Maloney DG, Jones AL (1980) Bile secretory apparatus: evidence for a vesicular transport mechanism for proteins in the rat, using horseradish peroxidase and (125I) insulin. Gastroenterology 78:1373–1388
Renston RH, Jones AL, Christansen WD (1980) Evidence for a vesicular transport mechanism in hepatocytes for biliary secretion of immunoglobulin A. Science 208:1276–1278
Hinton RH, Dobrota M, Mullock BM (1980) Haptoglobin-mediated transfer of haemoglobin from serum into bile. FEBS Lett 112:247–250
Lee VHL (1990) Mechanisms and facilitation of corneal drug penetration. J Contr Rel 11: 79–90
Thomas P, Toth CA, Zamcheck N (1982) The mechanism of biliary excretion of ai-acid glycoprotein in the rat: evidence for a molecular weight-dependent, nonreceptor-mediated pathway. Hepatology 2:800–803
Yen WCY, Lee VHL (1994) Paracellular transport of a proteolytically labile pentapeptide across the colonic and other intestinal segments of the albino rabbit: implications for peptide drag design. J Contr Rel 28:97–109
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lee, V.H.L. (1995). Oral Route of Peptide and Protein Drug Delivery. In: Absorption of Orally Administered Enzymes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79511-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-79511-4_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79513-8
Online ISBN: 978-3-642-79511-4
eBook Packages: Springer Book Archive